Eko Health, a leader in using artificial intelligence (AI) for the early detection of heart and lung diseases, has announced the appointment of Brent D. Lang to its Board of Directors. Lang, former Chairman and CEO of Vocera Communications, brings extensive experience in healthcare and technology to Eko, which is poised for significant growth and innovation in AI-driven diagnostics.
- Brent D. Lang’s Professional Background:
- Over 30 years of experience in healthcare and technology sectors.
- Former CEO of Vocera Communications, where he led the company through rapid growth, a successful IPO, and a $3 billion acquisition by Stryker.
- Recognized for his strategic vision and leadership in driving company success and innovation.
- Eko Health’s Mission and Recent Achievements:
- Focus on early detection of heart and lung diseases using AI technology.
- Recently surpassed 500,000 healthcare providers on its platform.
- Completed a $41 million Series D funding round.
- Achieved FDA clearance for the first AI algorithm to aid heart failure detection during routine exams.
- Statements from Eko Health Leadership:
- Connor Landgraf, CEO of Eko Health, highlights Lang’s experience and commitment to improving patient outcomes as vital to Eko’s growth.
- Landgraf emphasizes the strategic partnership with Lang to further enhance the accuracy and reach of Eko’s diagnostic platform.
- Brent D. Lang’s Vision for Eko:
- Expresses enthusiasm for joining Eko’s Board at a pivotal moment of growth.
- Aims to help Eko revolutionize the detection and management of heart and lung diseases worldwide.
- Committed to ensuring Eko’s platform reaches millions of patients and providers globally.
- Brent D. Lang’s Personal Accomplishments:
- Olympic gold medalist as part of the 1988 USA Men’s Swimming team.
- Serves as an independent director and treasurer for the USA Gymnastics Board of Directors.
- Holds an MBA from the Stanford Graduate School of Business and a bachelor’s degree in industrial and operations engineering from the University of Michigan.
Brent D. Lang’s appointment to Eko Health’s Board of Directors marks a significant step in the company’s journey to enhance its AI-driven diagnostic capabilities for heart and lung diseases. With his extensive background in healthcare technology and proven leadership, Lang is set to play a critical role in guiding Eko through its next phase of growth and innovation. His vision aligns with Eko’s mission to provide life-saving diagnostic tools to clinicians worldwide, positioning the company as a leader in AI health technology.
